Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Regulatory News & FDA Approvals » Genedrive Receives CE Mark for SARS-CoV-2 PCR Kit

Genedrive Receives CE Mark for SARS-CoV-2 PCR Kit

May 22, 2020
|
staff reporter

NEW YORK ─ Genedrive said Friday that it has received the CE mark for its Genedrive 96 SARS-CoV-2 Kit and is making it available for sale in the European Union, including the UK, and other countries that accept the mark. 

The Genedrive 96 SARS-CoV-2 Kit, a PCR assay that detects active infection, streamlines laboratory workflows, enabling more tests to be performed in a day, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Keep It (Partly) Virtual

A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.

Proteomics of Severity

Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.

For Cross-Protection

Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.

Genome Biology Papers on Regulatory Element, Single-Cell Integration, Sequence Simulation Tools

In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.

What's Popular?

In Regulatory News & FDA Approvals

  1. Qiagen MDx Sample Processing Platform Garners CE-IVD Mark

  2. FDA Grants Emergency Use Authorization for University of Illinois Coronavirus PCR Test

  3. FDA Reissues EUA for Fluidigm SARS-CoV-2 Test for Use With Azova Home Collection Kit

  4. Mobidiag SARS-CoV-2, Influenza A/B, RSV Test Receives CE Mark

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.